Thank you @myesmo.bsky.social #ESMOGI2025 chairs & organizing committee to bring GI #rarecancers to the stage and having me in good company. I hope I brought some awareness to #appendixcancers #pseudomyxoma #peritonealmesothelioma
#ESMOAmbassadors
@acpmpresearch.bsky.social
A woman who had eight organs removed after being diagnosed with a rare cancer has returned to work. #TCSC #cancer #cancersurvivor #cancertreatment
#pseudomyxoma #appendix
www.bbc.co.uk/news/article...
Study: Comparison of functional characterization of cancer stem cells in different tumor tissues of #pseudomyxoma peritonei.
#PMP
#HIPEC
#AppendixCancer
translational-medicine.biomedcentral.com/articles/10....
Congratulations to the recipients of the 14 ACPMP travel awards for #SSO2022! We are thrilled to support your work to improve the understanding and treatment of #appendixcancer and #pseudomyxoma!
It's #ClinicalTrials Awareness Week! ACPMP is committed to expanding patient access to clinical trials. Check out our up-to-date list of verified clinical trials for #appendixcancer and #pseudomyxoma peritonei at https://acpmp.org/clinical-trials
ACPMP is thrilled to report that the compound comprised of bromelain & n-acetylcysteine developed by Prof. David Morris & his Australian team to dissolve the mucin produced in connection with #pseudomyxoma has achieved orphan medicinal status in the EU! https://bit.ly/2QTR5Dv
French study presented at #PSOGI2018 concludes that recurrence of #pseudomyxoma peritonei (PMP) following optimal cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (#HIPEC) was rare after 5 years, and exceptional after...
